Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 26, 1998New England Journal of MedicineOpen Access

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

MFMiha FurlanUniversity of BernRRRodolfo RoblesUniversity of BernMGMiriam GalbuseraMario Negri Institute for Pharmacological Research

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Furlan et al. (1998) studied this question.

synapsesocial.com/papers/6a74492f2ea79cdc4d61ae77https://doi.org/10.1056/nejm199811263392202
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura1998 · 331 citations
  2. 2Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura1982 · 1,118 citations
  3. 3Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.1990 · 337 citations
  4. 4Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura1985 · 92 citations
  5. 5Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells1989 · 55 citations